Coverage and appearances featuring Organamet Bio and our founder, Dr. Doris Taylor — a leading voice in regenerative cardiac medicine.
Profiling Dr. Taylor's homecoming lecture at Mississippi University for Women, The Dispatch reports on her 21-year journey to bioengineer personalized hearts for transplant — and how, as CEO of Organamet Bio, she sees human trials approaching.
Read the article →Returning to her alma mater, Dr. Taylor presented "Building Heart in 2026: What I Learned at The W and Beyond," tracing her path from The W to the frontier of regenerative medicine before a packed Nissan Auditorium during Homecoming.
Read the announcement →Medscape examines the decellularization approach pioneered by Dr. Taylor and advanced by Organamet Bio — engineering patient-specific organ scaffolds to address the global transplant shortage.
Read the article →On the "Back of the Napkin" podcast — inspiring stories from biotech pioneers — Dr. Taylor shares the origin and ambition behind building human hearts, and the vision driving Organamet Bio.
Listen to the episode →A bioengineered ghost-heart scaffold was showcased at The Cure Gala's live auction, spotlighting and helping fund the cutting-edge regenerative research led by Dr. Taylor.
Event highlightWidely syndicated coverage explains how a cleaned-out scaffold combined with a patient's own stem cells could solve the organ-transplant shortage — the science at the heart of Organamet's platform.
Read the article →An in-depth interview with Dr. Taylor on her scientific breakthroughs, the road to clinical translation, and championing women in science and engineering.
Read the interview →Nominated as one of TIME's 100 Most Influential People in the World.
For pioneering perfusion decellularization, published in Nature Medicine.
Fellow of the AHA, ACC, and ESC; AIMBE Fellow (2020); Senior Member, National Academy of Inventors (2019).
AASCU national Distinguished Alumnus Award (2016); honorary Doctor of Science, MUW.
First functional repair of an injured heart with stem cells (1998); first whole-organ decellularization (2008).
Co-founder of Miromatrix Medical and Organamet Bio; former Director, Center for Cell and Organ Biotechnology, Texas Heart Institute.